SCHEMBL13495258

SCHEMBL13495258

O=C(O)c1cc(O)c2[nH]c(-c3cccs3)nc2c1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 6/20 0.51
HPGD P15428 5/20 0.51
PKM P14618 1/20 0.51
ERCC1 P07992 4/20 0.51
FEN1 P39748 4/20 0.51
ERCC4 Q92889 4/20 0.51
HDAC3 O15379 1/20 0.49
HDAC1 Q13547 1/20 0.49
HDAC2 Q92769 1/20 0.49
HDAC8 Q9BY41 1/20 0.49
HDAC6 Q9UBN7 1/20 0.49
ADORA3 P0DMS8 1/20 0.46
ADORA2A P29274 1/20 0.46
ADORA2B P29275 1/20 0.46
ADORA1 P30542 1/20 0.46
ALDH1A1 P00352 5/20 0.46
NPC1 O15118 3/20 0.46
RAB9A P51151 3/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
HSD17B10 Q99714 3/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1581142 0.89 ERCC1 (0.52) KDM4EHPGDPKMERCC1FEN1
SCHEMBL1580690 0.83 HDAC3 (0.46) KDM4EHPGDPKMERCC1FEN1
SCHEMBL21623639 0.79 HDAC3 (0.60) KDM4EHPGDPKMERCC1FEN1
SCHEMBL28391182 0.76 HDAC6 (0.75) KDM4EHPGDERCC1FEN1ERCC4
SCHEMBL29576620 0.76 HDAC6 (0.75) KDM4EHPGDERCC1FEN1ERCC4
SCHEMBL2313590 0.75 PBK (0.63) ERCC1FEN1ERCC4HDAC3HDAC1
SCHEMBL3557353 0.75 KDM4E (0.55) KDM4EHPGDPKMERCC1FEN1
SCHEMBL2340010 0.74 PBK (0.60) KDM4EHPGDERCC1FEN1ERCC4
SCHEMBL1580887 0.74 PBK (0.66) KDM4EHPGDERCC1FEN1ERCC4
SCHEMBL1580860 0.72 ERCC1 (0.46) KDM4EHPGDPKMERCC1FEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2010014794-A1 BENZOIMIDAZOLE DERIVATIVES AND GLYCOGEN SYNTHASE KINASE-3 BETA INHIBITORS CONTAINING THE SAME ONCOTHERAPY SCIENCE, INC. (JP) 2010-02-04 WO disclosed